A series of pyrazolyl sulfonamide compounds were prepared by a multi-step procedure involving preparation of phenyl pyrazolyl compounds (C1, C2) and their chlorosulfonated derivatives (C3-C5), which were then converted to...
The incorporation of heteroatoms into polycyclic aromatic hydrocarbons can alter their optical and electronic properties. Here we report the synthesis and characterization of a series of N,N’-diaryl diazadioxatetrahydropentacenes (4a-e) as well as and related N-phenyl azatrioxatetrahydropentacene and triazatetrahydrotetracene derivatives compounds (5,6) in order to investigate their photophysical properties and solid state organization. These compounds were prepared from readily available compounds via a concise approach involving copper-catalyzed aryl amination, followed by nucleophilic aromatic substitution. The compounds display bright luminescence in solution and in the solid state and strong solvatochromism. Single crystal X-ray diffraction of N,N’-aryl diazadioxatetrahydropentacenes (4b-d) revealed that all the compounds possessed nearly planar polycyclic aromatic systems with the pendent aryl groups nearly orthogonal to the pentacyclic core. Nonetheless, different substituents on the pendent aryl groups resulted in differences in photophysical properties because of differences in molecular geometries and solid-state packing. Interestingly, the N,N’-aryl diazadioxatetrahydropentacene bearing 2,6-dimethylphenyl groups attached to the nitrogen atoms (4d) gave two different polymorphs from the same solvent system, constituting a relatively rare example of concomitant polymorphism for such a rigid structure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.